Transcranial Magnetic Stimulation Aids PTSD in Eating Disorders

This article originally appeared here.
Share this content:
Transcranial Magnetic Stimulation Aids PTSD in Eating Disorders
Transcranial Magnetic Stimulation Aids PTSD in Eating Disorders

MONDAY, Aug. 21, 2017 (HealthDay News) -- Repetitive transcranial magnetic stimulation (rTMS) of the dorsomedial prefrontal cortex (DMPFC) seems to be beneficial for treatment of posttraumatic stress disorder (PTSD) in patients with eating disorders, according to research published online Aug. 16 in the International Journal of Eating Disorders.

D. Blake Woodside, M.D., from the University Health Network in Toronto, and colleagues presented a case series of 14 subjects with eating disorders and comorbid PTSD who received 20 to 30 neuronavigated DMPFC-rTMS treatments.

The researchers observed a reduction in the PTSD checklist-Civilian scores of 51.99 ± 27.24 percent overall (from a mean of 54.29 ± 19.34 to 24.86 ± 17.43 for before and after treatment). Eight of the 14 patients showed an improvement of more than 50 percent. There was an improvement in the Difficulties in Emotional Regulation Scale scores of 36.02 ± 24.24 percent overall (from 140.00 ± 22.09 to 89.29 ± 38.31 for before and after treatment). Five of the 14 subjects achieved improvement of more than 50 percent.

"These data may suggest that DMPFC-rTMS could be helpful in the treatment of PTSD in some eating disorder patients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »